试验注册
化疗致心脏毒性的正电子发射断层成像（PET）显像研究
Positron Emission Tomography (PET) Imaging of Chemotherapy-Induced Cardiotoxicity
作者：Washington University School of Medicine
ClinicalTrials.gov · 2026年9月24日 · Washington University School of Medicine
不需要生物学背景，多打比方
正在获取全文并生成讲解（拿不到全文就依据摘要）…
已等待 0 秒大约需要 10–20 秒
可以先看别的，做好了会自动出现在这里。
这篇还没有动画
动画会把研究的流程、作用机制和关键结果一步一步演示出来，每一步都标明出自原文哪里。制作大约需要一两分钟。
摘要Abstract
Brief summary: This study is a single center, phase 1 clinical imaging study designed to assess the role of 68Ga-Galmydar Positron Emission Tomography (PET) imaging for detection of cardiotoxicity in human subjects with breast cancer or lymphoma undergoing treatment with anthracycline for cancer therapy.
Conditions: Lymphoma Cancer; Breast Cancer; Cancer of the Breast; Non-Hodgkin Lymphoma; Hodgkin Lymphoma
Interventions: drug: 68Ga-Galmydar (Ga-Galmydar); device: PET/MRI (Positron Emission Tomography/Magnetic Resonance Imaging, PET/MR, PET-MRI); drug: 18F-FDG (F-FDG, FDG)
Phase: Phase 1
Enrollment: 36 (estimated)
Sponsor: Washington University School of Medicine (other)
Countries: United States
Status: not yet recruiting
还没有查过关联研究
我会去找这篇研究之前的基础工作、做类似事情的研究，以及之后引用它的研究，并说明每篇为什么相关。